2022/45/N/NZ7/03393
Keywords:
PBMC obesity insulin sensitivity macrophages inflammation liraglutide
Descriptors:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 209 230 PLN
Project start date (Y-m-d): 2023-02-01
Project end date (Y-m-d): 2026-01-31
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Publications will be made available after the final report has been accepted.